1066 On Other Exchanges
1066 is not on other exchanges.

shandong weigao gp medical-h (1066) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANDONG WEIGAO GP MEDICAL-H (1066)

Related News

No related news articles were found.

shandong weigao gp medical-h (1066) Related Businessweek News

No Related Businessweek News Found

shandong weigao gp medical-h (1066) Details

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, export, and sale of medical devices under the Jierui and Wego Ortho brands in the People’s Republic of China and internationally. The company operates through three divisions: Single Use Medical Device Products, Orthopaedic Products, and Blood Purification Products. It offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregator consumables, and blood sampling products; pre-filled syringes for pre-pack medication; and medical needles, which primarily include intravenous and syringe needles, intravenous catheter needles, wound management needles, blood sampling needles, and irregular needles. The company also provides orthopedic materials and instruments, such as trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment comprising puncture needles, dialyzers, and related consumables, as well as extracorporeal blood circuits for blood purification sets. In addition, it engages in the wholesale, purchase, and sale of disposable sterile medical devices; and various financial leasing business of medical equipment. Further, the company provides logistics and storage services; sells computer software; and asset management and enterprise consulting services. Additionally, it offers industrial automatic equipment and parts; hemo-dialysis equipment; medical PVC granules, plastic packing bags, and carton boxes; and molds. The company serves hospitals, blood stations, and other medical units; and distributors. The company was founded in 2000 and is based in Weihai, the People’s Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.

10,575 Employees
Last Reported Date: 04/19/17
Founded in 2000

shandong weigao gp medical-h (1066) Top Compensated Officers

Vice Chairman and Chief Executive Officer
Total Annual Compensation: CNY1.5M
Executive Director
Total Annual Compensation: CNY10.2M
Executive Director
Total Annual Compensation: CNY1.4M
Chairman and Compliance Officer
Total Annual Compensation: CNY1.7M
Compensation as of Fiscal Year 2016.
shandong weigao gp medical-h
Shandong Weigao Group Medical Polymer Company Limited Proposes to Amend Articles of Association

Shandong Weigao Group Medical Polymer Company Limited announced that at its AGM to be held on June 12, 2017, proposed to amend Articles of Association.

Shandong Weigao Group Medical Polymer Co., Limited Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2016

Shandong Weigao Group Medical Polymer Co., Limited announced audited consolidated earnings results for the year ended December 31, 2016. For the year, the company reported revenue of RMB 6,730,340,000 compared to RMB 5,918,930,000 a year ago. Profit before taxation RMB 1,314,346,000 compared to RMB 1,335,505,000 a year ago. Profit for the year attributable to owners of the company was RMB 1,105,933,000 compared to RMB 1,112,736,000 a year ago. Basic and diluted earnings per share was RMB 0.25 compared to RMB 0.25 a year ago. Net cash flow from operating activities was RMB 1,053,139,000 compared to RMB 1,052,770,000 a year ago. Purchases of property, plant and equipment was RMB 592,940,000 compared to RMB 1,068,138,000 a year ago. Deposits paid for acquiring property, plant and equipment was RMB 26,729,000 compared to RMB 45,373,000 a year ago.

Shandong Weigao Group Medical Polymer Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2016, Payable on July 21, 2017

The Board of Shandong Weigao Group Medical Polymer Co. Ltd. proposed the distribution of a final dividend for the year ended December 31, 2016 RMB 0.046 per share totaling RMB 208,027,000 compared to RMB 0.036 per share a year ago, which will be subject to the approval of shareholders of the company at the forthcoming 2016 annual general meeting. The dividend will be paid on July 21, 2017.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1066 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1066.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1066 Industry Range
Price/Earnings 22.0x
Price/Sales 3.6x
Price/Book 2.1x
Price/Cash Flow 22.3x
TEV/Sales 2.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANDONG WEIGAO GP MEDICAL-H, please visit www.weigaogroup.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.